NCT00097409View on ClinicalTrials.gov

Ispinesib In Subjects With Platinum-Taxane-Refractory Or Resistant Relapsed Ovarian Cancer

PHASE2CompletedINTERVENTIONAL
Enrollment

35

Participants

Timeline

Start Date

December 31, 2004

Primary Completion Date

May 31, 2007

Study Completion Date

May 31, 2007

Conditions
Ovarian Cancer
Interventions
DRUG

Ispinesib

Trial Locations (9)

35205

GSK Investigational Site, Birmingham

37203

GSK Investigational Site, Nashville

44124

GSK Investigational Site, Mayfield Heights

53792

GSK Investigational Site, Madison

63110

GSK Investigational Site, St Louis

70115

GSK Investigational Site, New Orleans

73104

GSK Investigational Site, Oklahoma City

98101

GSK Investigational Site, Seattle

19001-3788

GSK Investigational Site, Abington

Sponsors

Lead Sponsor

GlaxoSmithKline
All Listed Sponsors
lead

GlaxoSmithKline

INDUSTRY